Clinical Research 11 min read

Lilly's SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN: weight-loss maintenance with lower-dose Zepbound or oral Foundayo

Two Phase 3 trials presented at ECO 2026 and published in The Lancet and Nature Medicine show that stepping down or switching to a pill preserves most prior weight loss.

· Updated